Ceylon Cinnamon (Cinnamomum verum)

Ceylon cinnamon (Cinnamomum verum) contains cinnamaldehyde and proanthocyanidins that support glucose metabolism and cardiovascular health. These compounds work by enhancing insulin sensitivity and reducing inflammatory markers associated with metabolic dysfunction.

Origin & History

Ceylon Cinnamon (Cinnamomum verum) is a spice derived from the inner bark of an evergreen tree native to Sri Lanka and southern India. The bark is peeled from branches and curls into quills as it dries. For clinical research, water extracts are often produced by boiling and concentrating the bark.

Historical & Cultural Context

Ceylon Cinnamon has been used for millennia in Sri Lankan Ayurvedic and South Asian traditional medicine. It was historically employed for its purported antimicrobial, antioxidant, blood glucose-lowering, and cardiovascular benefits, which has prompted modern clinical investigation.

Health Benefits

["\u2022 Supports Healthy Cholesterol Levels: A phase I trial in 30 healthy adults found that daily doses up to 500 mg significantly reduced total cholesterol and LDL-cholesterol (PMID: 28962661). Evidence quality: Preliminary.", "\u2022 Improves Glycemic Control in T2DM: A 4-month RCT with 210 type 2 diabetes patients showed that 250-500 mg daily significantly lowered fasting plasma glucose and HbA1c (PMID: 41412108). Evidence quality: Moderate.", "\u2022 Enhances Insulin Sensitivity: The same RCT in T2DM patients demonstrated significant improvements in insulin resistance and \u03b2-cell function compared to placebo (PMID: 41412108). Evidence quality: Moderate.", "\u2022 Reduces LDL-Cholesterol in T2DM: In the T2DM trial, the 500 mg dose group experienced a significant reduction in total and LDL cholesterol, reinforcing its lipid-lowering effects (PMID: 41412108). Evidence quality: Moderate.", "\u2022 May Aid Weight Management: While evidence for glycemic control is mixed across studies, some meta-analyses indicate a potential for Ceylon Cinnamon to support reductions in BMI and body weight (PMIDs: 24019277, 35365881). Evidence quality: Mixed."]

How It Works

Ceylon cinnamon's primary bioactive compound cinnamaldehyde activates insulin receptors and enhances glucose uptake in skeletal muscle cells. Proanthocyanidins inhibit α-glucosidase and α-amylase enzymes, slowing carbohydrate digestion and glucose absorption. The compound also modulates HMG-CoA reductase activity, contributing to cholesterol-lowering effects.

Scientific Research

Clinical evidence includes a phase I trial in 30 healthy adults showing cholesterol reduction (PMID: 28962661) and a randomized controlled trial in 210 type 2 diabetes patients demonstrating improved glycemic control and lipid profiles (PMID: 41412108). However, meta-analyses report mixed results on its glycemic effects, highlighting the need for larger, longer-term studies (PMIDs: 24019277, 35365881).

Clinical Summary

A phase I trial in 30 healthy adults showed daily doses up to 500 mg significantly reduced total cholesterol and LDL-cholesterol levels. A 4-month randomized controlled trial with 210 type 2 diabetes patients demonstrated improved glycemic control parameters. Current evidence is preliminary but promising, with most studies using standardized extracts containing 1-3% cinnamaldehyde. Larger, longer-term trials are needed to establish definitive therapeutic protocols.

Nutritional Profile

Ceylon Cinnamon (Cinnamomum verum) bark powder (per 100g serving as reference): Calories ~247 kcal, Carbohydrates ~80.6g (of which dietary fiber ~53.1g, representing its dominant macronutrient), Protein ~3.99g, Total Fat ~1.24g (primarily linolenic and oleic acids). Key Micronutrients: Calcium ~1002mg (high bioavailability concern due to lower oxalate content vs. Cassia), Iron ~8.32mg, Manganese ~17.5mg (exceptionally high, ~760% DV), Magnesium ~60mg, Phosphorus ~64mg, Potassium ~431mg, Vitamin K ~31.2mcg, Vitamin A ~15 IU, small amounts of B vitamins (B1 ~0.022mg, B2 ~0.041mg, B6 ~0.158mg). Bioactive Compounds: Cinnamaldehyde (primary volatile oil constituent, ~50-90% of essential oil, responsible for flavor and many bioactivities), Eugenol (~1-5% of essential oil, significantly higher proportion than in Cassia, contributing anti-inflammatory properties), Cinnamyl acetate, Linalool, and Beta-caryophyllene in the essential oil fraction. Polyphenols: Procyanidin type-A polymers (condensed tannins, primarily cinnamtannin B1), Epicatechin, Catechin, and Quercetin glycosides (~8,000-12,000 mg gallic acid equivalents per 100g ORAC value). Type-A procyanidins are linked to insulin-mimetic activity. Crucially, Ceylon cinnamon contains very low levels of Coumarin (<0.004% dry weight, approximately 0.017mg/g vs. Cassia's 1-12mg/g), making it significantly safer for regular consumption. The water-soluble polyphenolic polymer fraction (MHCP - methylhydroxychalcone polymer) at estimated 1-3% dry weight is considered a primary contributor to glycemic benefits. Fiber is predominantly insoluble (~80% of total fiber), with some pectin fractions. Bioavailability notes: Cinnamaldehyde is rapidly absorbed through the GI tract but undergoes extensive first-pass metabolism to cinnamic acid and hippuric acid; bioavailability of intact cinnamaldehyde is low but metabolites remain biologically active. Polyphenol absorption is moderate and enhanced with fat co-ingestion; the polymer MHCP may have limited direct absorption but exerts local intestinal effects.

Preparation & Dosage

Clinical trials have used non-standardized water extracts. A phase I study in healthy adults used escalating daily doses from 85 mg to 500 mg over three months. An RCT in type 2 diabetes patients used 250 mg and 500 mg daily for four months. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Berberine, Alpha-Lipoic Acid, Chromium, Fenugreek

Safety & Interactions

Ceylon cinnamon is generally well-tolerated at therapeutic doses up to 6 grams daily. Unlike Cassia cinnamon, Ceylon contains minimal coumarin, reducing hepatotoxicity risk. May enhance effects of diabetes medications, requiring blood glucose monitoring. Pregnant and nursing women should avoid supplemental doses due to insufficient safety data.